NCT05281783
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Interventional Ultrasonography Unit, Tropical Medicine Department, Beni-Suef University Hospitals Banī Suwayf, Egypt
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,051 public trials
1,181 recruiting studies
Adenocarcinoma trial results
NCT02785835
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +32 more
- Locations
-
- Hospital de Orihuela Orihuela, Alicante, Spain
- Hospital Clínico Universitario de San Juan Sant Joan d'Alacant, Alicante, Spain
- Hospital Marina Baixa Villajoyosa, Alicante, Spain
- Hospital German Trias i Pujol Badalona, Barcelona, Spain
NCT04498611
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Seoul National University Hospital Seoul, Jongno-gu, South Korea
NCT01059188
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
- Locations
-
- Saint Claraspital AG Basel, Switzerland
- Universitaetsspital-Basel Basel, Switzerland
- Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
- Inselspital Bern Bern, Switzerland
Completed
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
NCT02526017
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
- Locations
-
- Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States
- Moores UC San Diego Cancer Center La Jolla, California, United States
- Norris Comprehensive Cancer Center, University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
NCT04008082
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Eisai Trial Site #1 Osaka, Japan
- Eisai Trial Site #2 Tokyo, Japan
NCT01961531
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- Watson Cancer Center Lakeland, Florida, United States
- Rhode Island Hospital Providence, Rhode Island, United States
NCT03663946
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Local Institution Tokyo, Japan
NCT03352934
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +8 more
- Locations
-
- Poliklinik für Innere Medizin I Universitätsklinikum Halle Halle, Germany
- Nationales Centrum für Tumorerkrankungen Universitätsklinikum Heidelberg Heidelberg, Germany
- Schwerpunkt Endokrinologie und Stoffwechselerkrankungen Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany
- Klinik für Innere Medizin, Abteilung Gastroenterologie Universitätsklinikum Gießen und Marburg Marburg, Germany
NCT02178358
- Conditions
- Adenocarcinoma, Bone Diseases, Bone Diseases, Developmental, +16 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China